Catégorie : Plan

The 13 first-line pre-indications validated by the Operating Committee correspond to clinical indications positively evaluated by the british National Health Service (NHS).

Dissemination of a questionnaire to the rare diseases and cancer care professionals for the submission of pre-indication projects. It explains: the interest of sequencing the complete genome in the patient care pathway, the technical constraints, the organisation to be set up and the expected volumes.

DEFIDIAG is a clinical trial in intellectual deficiency.

Choice of sequence technologies, definition of storage and calculation architecture which will be deployed (shared memory calculator, computing cluster…), software specification (purchase of licences, software compliance) .

In June 2019, information notices and consent forms – in their various forms: rare diseases, cancer; adults, minors, protected persons– were made available to the genomic platforms of the plan to be used during interviews with the first patients. These documents were created as « draft » versions: Obtaining consent in genetics is organised primarily by regulation […]

Dissemination of a questionnaire to the rare disease and cancer care sectors for the submission of pre-indication projects. The interest of complete genome sequencing in the patient care pathway, the technical constraints, the organisation to be set up and the expected volumes are presented.

Poll of the entire training offer of French universities and public sector engineering schools through their web sites, including the training offer of medicine research and training units (UFR). This first objective was to identify the training that we believe to be necessary to deploy the French Plan for Genomic Medicine 2025. Only immediate vocational […]

The first task addressed by the working group was to provide professionals with operational documents in an ethical manner, necessary to start the first sequencing.     Indeed, two types of documents must be submitted to patients by the medical specialist before any diagnosis in the framework of the plan: The information notice provides, in written and […]

The « Ethics, regulation and society » working group is led by:  the Directorate-General for Health  under the aegis of Arnaud de Guerra (DGS), Aviesan, with Anne Cambon-Thomsen, director of research director, CNRS, member of the European Group on Ethics in Science and New Technologies, and Christine Lemaitre, representative of the Ethics Committee, Inserm. This group includes the various […]

ICPerMed was launched at workshops organised by the European Commission. It includes non-profit public and private bodies for funding health research and the setting up of public policies. ICPerMed wants to contribute to the implementation of personalised medicine for the benefit of patients, citizens and society as a whole and to facilitate the coordination of research […]